Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
November 29, 2005
Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie)
P Thomas, G Robinet, S Gouva, et al.
American Journal of Clinical Oncology
|
August 24, 2000
Lenograstim as support for ACE chemotherapy of small-cell lung cancer: a phase III, multicenter, randomized study
U Gatzemeier, J P Kleisbauer, P Drings, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 17, 2005
Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC)
A Vergnenègre, C Daniel, H Léna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 1, 1996
Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'
M Pérol, J C Guérin, P Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer
U Gatzemeier, J von Pawel, M Gottfried, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 1, 1997
Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.)
P Thomas, J P Kleisbauer, G Robinet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study
M Pérol, H Léna, P Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2006
Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study
A B Cortot, L Gerinière, G Robinet, et al.
BMC Cancer
|
November 8, 2015
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)
C Raynaud, L Greillier, J Mazieres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study
P Thomas, O Castelnau, D Paillotin, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Lung Cancer (Amsterdam, Netherlands)
|
November 29, 2005
Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie)
P Thomas, G Robinet, S Gouva, et al.
American Journal of Clinical Oncology
|
August 24, 2000
Lenograstim as support for ACE chemotherapy of small-cell lung cancer: a phase III, multicenter, randomized study
U Gatzemeier, J P Kleisbauer, P Drings, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 17, 2005
Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC)
A Vergnenègre, C Daniel, H Léna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 1, 1996
Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'
M Pérol, J C Guérin, P Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer
U Gatzemeier, J von Pawel, M Gottfried, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 1, 1997
Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.)
P Thomas, J P Kleisbauer, G Robinet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study
M Pérol, H Léna, P Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2006
Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study
A B Cortot, L Gerinière, G Robinet, et al.
BMC Cancer
|
November 8, 2015
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)
C Raynaud, L Greillier, J Mazieres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study
P Thomas, O Castelnau, D Paillotin, et al.
Page
of 7